Search NASA⌕ Search

Engineering topics

Hirschmugl, Carol

Publications and source records attributed to Hirschmugl, Carol.

Scale-up Production of Graphene Monoxide for Next-Generation LIB Anodes (AMMTO Final Report)

COnovate, LLC has developed a patented material called graphene monoxide and demonstrated that its unique chemical and crystal structure enables lithium-ion batteries (LIB) with greater specific capacity, safer and faster charging, and better low temperature performance than the industry standard. The current capability gap with COnovate’s technology is to scale up this new active anode material, developing processing technology to commercially relevant levels. This project will develop the means for progressive scale-up to 100g, 1kg, and 10kg levels, incorporating industrial synthesis and processing technologies, and deliver an industrial procedure/batch record draft for use by potential full-scale manufacturers to develop metric-ton production levels. The project goals of 10kg production and industrial procedure for full-scale production are necessary for COnovate’s customers to adequately evaluate and adopt their technology, and to pursue purchase orders for tons of material. MERF will confirm material analytics and performance in half cell tests during scaling and deliver materials to COnovate for QA/QC testing during the iterative scale up efforts. The final product batches will be delivered to COnovate for battery assembly and lifetime testing.

25 ENERGY STORAGE↗

Development of Fe 3 O 4 core–TiO 2 shell nanocomposites and nanoconjugates as a foundation for neuroblastoma radiosensitization

Neuroblastoma is the most common extracranial solid malignancy in childhood which, despite the current progress in radiotherapy and chemotherapy protocols, still has a high mortality rate in high risk tumors. Nanomedicine offers exciting and unexploited opportunities to overcome the shortcomings of conventional medicine. The photocatalytic properties of Fe 3 O 4 core-TiO 2 shell nanocomposites and their potential for cell specific targeting suggest that nanoconstructs produced using Fe 3 O 4 core-TiO 2 shell nanocomposites could be used to enhance radiation effects in neuroblastoma. In this study, we evaluated bare, metaiodobenzylguanidine (MIBG) and 3,4-Dihydroxyphenylacetic acid (DOPAC) coated Fe 3 O4@TiO 2 as potential radiosensitizers for neuroblastoma in vitro. The uptake of bare and MIBG coated nanocomposites modestly sensitized neuroblastoma cells to ionizing radiation. Conversely, cells exposed to DOPAC coated nanocomposites exhibited a five-fold enhanced sensitivity to radiation, increased numbers of radiation induced DNA double-strand breaks, and apoptotic cell death. The addition of a peptide mimic of the epidermal growth factor (EGF) to nanoconjugates coated with MIBG altered their intracellular distribution. Cryo X-ray fluorescence microscopy tomography of frozen hydrated cells treated with these nanoconjugates revealed cytoplasmic as well as nuclear distribution of the nanoconstructs. The intracellular distribution pattern of different nanoconjugates used in this study was different for different nanoconjugate surface molecules. Cells exposed to DOPAC covered nanoconjugates showed the smallest nanoconjugate uptake, with the most prominent pattern of large intracellular aggregates. Interestingly, cells treated with this nanoconjugate also showed the most pronounced radiosensitization effect in combination with the external beam x-ray irradiation. Further studies are necessary to evaluate mechanistic basis for this increased radiosensitization effect. Preliminary studies with the nanoparticles carrying an EGF mimicking peptide showed that this approach to targeting could perhaps be combined with a different approach to radiosensitization – use of nanoconjugates in combination with the radioactive iodine. Much additional work will be necessary in order to evaluate possible benefits of targeted nanoconjugates carrying radionuclides.

77 NANOSCIENCE AND NANOTECHNOLOGY↗